Bardy Diagnostics, developers of a remote cardiac monitoring chest patch, has raised $35.5 million to help fund its platform and expand its sales force. The series B round, led by River Cities Capital ...
Seattle-based medical device company Bardy Diagnostics today announced a $35.5 million funding round led by River Cities Capital Fund. The company makes the Carnation Ambulatory Monitor (CAM), which ...
SEATTLE, Oct. 24, 2019 /PRNewswire/ -- Bardy Diagnostics, Inc., ("BardyDx"), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced that it was selected ...
CHARLOTTE, N.C., Nov. 16, 2017 /PRNewswire/ -- Bardy Diagnostics, Inc., a leading provider of ambulatory cardiac technologies and custom data solutions, including the Carnation Ambulatory Monitor™ ...
Hillrom is calling off a planned acquisition of cardiac monitor-maker Bardy Diagnostics, saying the closing conditions of the deal had not been satisfied. The Chicago-based medical technology company ...
Cardiac-monitoring device maker Bardy Diagnostics has agreed to an acquisition by Hillrom, a medical technology provider specializing in smart hospital beds and other connected monitoring tools. The ...
A January acquisition deal between medical technology provider Hillrom and cardiac monitoring device maker Bardy Diagnostics has landed in rocky waters, with Hillrom looking to back out of the ...
Hillrom, a publicly-traded medical device and digital health company based in Chicago, will pay $375 million to acquire Seattle startup Bardy Diagnostics. Founded in 2013, Bardy set out to change the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results